atenolol has been researched along with clenbuterol in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Folco, GC; Omini, C; Puglisi, L; Rossoni, G; Somerville, AR | 1 |
| Berrow, NS; Lacey, RJ; Morgan, NG; Scarpello, JH | 1 |
| Akahane, K; Chiba, S; Furukawa, Y; Haniuda, M; Ogiwara, Y | 1 |
| Kemp, GJ; Odoom, JE; Radda, GK | 1 |
| Höcht, C; Opezzo, JA; Taira, CA | 1 |
| Baeyens, WR; De Beer, T; Dilinuer, M; Fei, GT; Ouyang, J; Wang, Y; Zhou, S | 1 |
| Allen, RE; Anderson, MJ; Antolic, AT; Camacho, LE; Davis, MA; Goyal, R; Hay, WW; Kelly, AC; Limesand, SW; Papas, KK; Steyn, LV; Yates, DT | 1 |
9 other study(ies) available for atenolol and clenbuterol
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interaction between beta 1 and beta 2 adrenoceptors in the isolated guinea-pig trachea.
Topics: Airway Resistance; Albuterol; Animals; Atenolol; Clenbuterol; Dose-Response Relationship, Drug; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Pilocarpine; Practolol; Receptors, Adrenergic; Receptors, Adrenergic, beta; Trachea | 1979 |
Selective stimulation of glucagon secretion by beta 2-adrenoceptors in isolated islets of Langerhans of the rat.
Topics: 1-Methyl-3-isobutylxanthine; Adrenergic beta-Antagonists; Animals; Atenolol; Clenbuterol; Colforsin; Cyclic AMP; Glucagon; In Vitro Techniques; Insulin; Islets of Langerhans; Male; Propanolamines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta | 1991 |
Beta-adrenoceptor blocking effects of a selective beta 2-agonist, mabuterol, on the isolated, blood-perfused right atrium of the dog.
Topics: 1-Methyl-3-isobutylxanthine; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Calcium Chloride; Clenbuterol; Dobutamine; Dogs; Ethanolamines; Heart; Heart Rate; In Vitro Techniques; Isoproterenol; Myocardial Contraction; Procaterol; Propanolamines | 1989 |
The regulation of total creatine content in a myoblast cell line.
Topics: Animals; Atenolol; Bucladesine; Butoxamine; Cell Line; Clenbuterol; Creatine; Energy Metabolism; Insulin; Insulin-Like Growth Factor I; Isoproterenol; Labetalol; Methoxamine; Mice; Muscle, Skeletal; Norepinephrine; Phentolamine; Propranolol; Sodium; Triiodothyronine | 1996 |
Anterior hypothalamic beta-adrenergic activity in the maintenance of hypertension in aortic coarctated rats.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Anterior Hypothalamic Nucleus; Aortic Coarctation; Atenolol; Blood Pressure; Clenbuterol; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Hypertension; Hypotension; Isoproterenol; Male; Metoprolol; Microinjections; Propranolol; Rats; Rats, Wistar; Receptors, Adrenergic, beta | 2004 |
Simultaneous separation of eight beta-adrenergic drugs using titanium dioxide nanoparticles as additive in capillary electrophoresis.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Atenolol; Buffers; Celiprolol; Clenbuterol; Electroosmosis; Electrophoresis, Capillary; Fenoterol; Hydrogen-Ion Concentration; Isoproterenol; Metal Nanoparticles; Metoprolol; Propranolol; Reproducibility of Results; Terbutaline; Titanium; Uncertainty | 2008 |
Postnatal β2 adrenergic treatment improves insulin sensitivity in lambs with IUGR but not persistent defects in pancreatic islets or skeletal muscle.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Animals; Atenolol; Cells, Cultured; Clenbuterol; Female; Fetal Growth Retardation; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 4; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Muscle, Skeletal; Receptors, Adrenergic, beta-2; Sheep | 2019 |